Expression and purification of soluble single-chain Fv against human fibroblast growth factor receptor 3 by fused with Sumo tag in Escherichia coli
Abstract
Background: Overexpression or mutated activation of Fibroblast growth factor receptor 3 (FGFR3) is involved in the pathogenesis of many tumors. More and more studies focus on the potential usage of therapeutic antibodies against FGFR3.
Results: In this study, a novel single-chain Fv (ScFv) against FGFR3 was prepared and characterized. To achieve the soluble expression, ScFv was fused with Sumo (Small ubiquitin-related modifier) by polymerase chain reaction (PCR), and cloned into pET-20b. The recombinant bacteria were induced by 0.5 mM Isopropyl-β-D- thiogalactopyranoside (IPTG) for 16 h at 20ºC, and the supernatant liquid of Sumo-ScFv was harvested and purified by Ni-NTA chromatography. After cleaved by the Sumo protease, the recombinant ScFv was released from the fusion protein, and further purified by Ni-NTA chromatography. The purity of ScFv was shown to be higher than 95% and their yield reached 4 mg per liter of bacterial culture. In vitro data showed ScFv can significantly attenuate FGF9-induced the phosphorylation of FGFR3.
Conclusion: We provide a novel method to produce soluble expression and bioactive functions of ScFv in Escherichia coli.